Entera Bio Ltd. Ordinary Shares (ENTX) is a publicly traded Healthcare sector company. As of May 21, 2026, ENTX trades at $1.23 with a market cap of $60.55M and a P/E ratio of 4.97. ENTX moved +0.00% today. Year to date, ENTX is -29.94%; over the trailing twelve months it is -39.81%. Its 52-week range spans $0.91 to $3.22. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces ENTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading ENTX stock inside the company?
Recent ENTX insider activity includes Germano Geno J bought 20.00K, Ellis Sean bought 10.00K, Taitel Haya bought 7.50K, Germano Geno J bought 20.00K, and Ellis Sean bought 18.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
ENTX Key Metrics
Key financial metrics for ENTX
Metric
Value
Price
$1.23
Market Cap
$60.55M
P/E Ratio
4.97
EPS
$0.25
Dividend Yield
0.00%
52-Week High
$3.22
52-Week Low
$0.91
Volume
0
Avg Volume
0
Revenue (TTM)
$42.00K
Net Income
$-11.44M
Gross Margin
0.00%
Recent ENTX Insider Trades
Germano Geno J bought 20.00K (~$26.00K) on Mar 9, 2026.
Ellis Sean bought 10.00K (~$12.30K) on Mar 5, 2026.
Taitel Haya bought 7.50K (~$11.10K) on Feb 10, 2026.
Germano Geno J bought 20.00K (~$29.80K) on Feb 10, 2026.
Ellis Sean bought 18.00K (~$22.32K) on Feb 9, 2026.
Recent ENTX insider activity includes Germano Geno J bought 20.00K, Ellis Sean bought 10.00K, Taitel Haya bought 7.50K, Germano Geno J bought 20.00K, and Ellis Sean bought 18.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ENTX?
Yes. Rallies tracks ENTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ENTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ENTX. It does not provide personalized investment advice.
